Search research articles
Contact Us
Filters
Showing results (71-80 of 715) with videos related to
Page
of 72
Sort By:
Lancet (London, England)
|
December 16, 2000
Intracranial haemorrhage with bolus thrombolytic agents
D Collen, B Sobel
Thrombosis Research
|
June 1, 1976
Immunochemical distinction between the inhibitors of plasminogen activation and antiplasmin in human plasma
U Hender, D Collen
Blood
|
February 1, 1979
Turnover of antiplasmin, the fast-acting plasmin inhibitor of plasma
D Collen, B Wiman
Thrombosis and Haemostasis
|
July 1, 1995
Gene targeting and gene transfer studies of the biological role of the plasminogen/plasmin system
P Carmeliet, D Collen
Thrombosis Research
|
October 15, 1998
Development and disease in proteinase-deficient mice: role of the plasminogen, matrix metalloproteinase and coagulation system
P Carmeliet, D Collen
The Journal of Laboratory and Clinical Medicine
|
January 1, 1987
Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: modulation by thrombin, endotoxin, and histamine
M Hanss, D Collen
Thrombosis Research
|
June 1, 1978
Affinity chromatography of soluble fibrin in human plasma on insolubilized fibrinogen and fragment D
N Semeraro, D Collen
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 31, 1997
beta-VLDL hypercholesterolemia relative to LDL hypercholesterolemia is associated with higher levels of oxidized lipoproteins and a more rapid progression of coronary atherosclerosis in rabbits
P Holvoet, D Collen
Scandinavian Journal of Clinical and Laboratory Investigation
|
June 1, 1977
Comparison of the reactions of neutral granulocyte proteases with the major plasma protease inhibitors and with antiplasmin
K Ohlsson, D Collen
Journal of the American College of Cardiology
|
December 1, 1986
Pharmacology of thrombolytic drugs
M Verstraete, D Collen
Page
of 72
Search research articles
Search
Showing results (71-80 of 715) with videos related to
Sort By:
Page
of 72
Lancet (London, England)
|
December 16, 2000
Intracranial haemorrhage with bolus thrombolytic agents
D Collen, B Sobel
Thrombosis Research
|
June 1, 1976
Immunochemical distinction between the inhibitors of plasminogen activation and antiplasmin in human plasma
U Hender, D Collen
Blood
|
February 1, 1979
Turnover of antiplasmin, the fast-acting plasmin inhibitor of plasma
D Collen, B Wiman
Thrombosis and Haemostasis
|
July 1, 1995
Gene targeting and gene transfer studies of the biological role of the plasminogen/plasmin system
P Carmeliet, D Collen
Thrombosis Research
|
October 15, 1998
Development and disease in proteinase-deficient mice: role of the plasminogen, matrix metalloproteinase and coagulation system
P Carmeliet, D Collen
The Journal of Laboratory and Clinical Medicine
|
January 1, 1987
Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: modulation by thrombin, endotoxin, and histamine
M Hanss, D Collen
Thrombosis Research
|
June 1, 1978
Affinity chromatography of soluble fibrin in human plasma on insolubilized fibrinogen and fragment D
N Semeraro, D Collen
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 31, 1997
beta-VLDL hypercholesterolemia relative to LDL hypercholesterolemia is associated with higher levels of oxidized lipoproteins and a more rapid progression of coronary atherosclerosis in rabbits
P Holvoet, D Collen
Scandinavian Journal of Clinical and Laboratory Investigation
|
June 1, 1977
Comparison of the reactions of neutral granulocyte proteases with the major plasma protease inhibitors and with antiplasmin
K Ohlsson, D Collen
Journal of the American College of Cardiology
|
December 1, 1986
Pharmacology of thrombolytic drugs
M Verstraete, D Collen
Page
of 72